Form 4: Seer Inc. CCO Anthony Bazarko Receives Equity Grant
Statement of Changes in Beneficial Ownership
Seer, Inc. Chief Commercial Officer Anthony R. Bazarko was granted 75,000 restricted stock units and 225,000 stock options.
Summary
- Anthony R. Bazarko, Chief Commercial Officer of Seer, Inc., received an equity compensation package on May 8, 2026.
- The grant includes 75,000 restricted stock units (RSUs) which vest in four equal annual installments starting May 15, 2027.
- The grant also includes 225,000 employee stock options with an exercise price of $1.87 per share.
- The stock options vest over four years, with the first 25% vesting on May 4, 2027, and the remainder vesting in equal monthly installments thereafter.
Sentiment
Score: 5
Explanation: StockSavvy.ai views this as a neutral administrative filing regarding executive compensation, which is expected behavior for a publicly traded company.
Positives
- Equity-based compensation aligns the interests of the Chief Commercial Officer with long-term shareholder value.
- The multi-year vesting schedule encourages executive retention.
Negatives
- The issuance of new equity results in potential dilution for existing shareholders.
Risks
- Future share price volatility may impact the ultimate value of the granted equity.
- The company's ability to meet performance goals required to maintain executive retention remains a factor.
Future Outlook
The filing does not provide forward-looking financial guidance, as it is a standard disclosure of executive compensation.
Industry Context
StockSavvy.ai notes that equity grants for C-suite executives are standard practice in the biotechnology and life sciences sectors to incentivize leadership during product development and commercialization phases.
Comparison to Industry Standards
- The use of a four-year vesting schedule is consistent with standard corporate governance practices for executive compensation in the U.S. biotech industry.
- The mix of RSUs and stock options is a common structure used by companies like Seer to balance retention and performance-based incentives.
Stakeholder Impact
- Shareholders may experience minor dilution from the issuance of new equity.
Next Steps
- Vesting of restricted stock units beginning May 15, 2027.
- Vesting of stock options beginning May 4, 2027.
Key Dates
| Date | Description |
|---|---|
| 05/08/2026 | Date of transaction and grant of equity awards. |
| 05/04/2027 | Initial vesting date for stock options. |
| 05/15/2027 | Initial vesting date for restricted stock units. |
| 05/08/2036 | Expiration date for the granted stock options. |
Keywords
Seer Inc, SEER, Form 4, Insider Trading, Equity Compensation, Chief Commercial Officer
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.